Hangzhou Tigermed Consulting Co., Ltd Share Price
Equities
300347
CNE100001KV8
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.37 CNY | +1.06% |
|
-3.81% | +1.18% |
| Capitalization | 4.68TCr 678.46Cr 584.97Cr 528.06Cr 506.68Cr 923.93Cr 62TCr 966.94Cr 6.24TCr 2.5TCr 30TCr 2.55TCr 2.49TCr 1,06900Cr | P/E ratio 2025 * |
41.6x | P/E ratio 2026 * | 36.1x |
|---|---|---|---|---|---|
| Enterprise value | 4.63TCr 671.89Cr 579.3Cr 522.94Cr 501.77Cr 914.98Cr 62TCr 957.57Cr 6.18TCr 2.48TCr 30TCr 2.52TCr 2.47TCr 1,05900Cr | EV / Sales 2025 * |
6.67x | EV / Sales 2026 * | 5.87x |
| Free-Float |
72.37% | Yield 2025 * |
0.78% | Yield 2026 * | 0.82% |
| 1 day | +1.06% | ||
| 1 week | -3.81% | ||
| Current month | -3.81% | ||
| 1 month | -12.61% | ||
| 3 months | +16.02% | ||
| 6 months | -13.83% | ||
| Current year | +1.18% |
| 1 week | 55.8 |  | 59.65 |
| 1 month | 55.8 | | 67.85 |
| Current year | 55.8 | | 67.85 |
| 1 year | 41.61 | | 71.9 |
| 3 years | 36.12 | | 113.75 |
| 5 years | 36.12 | | 209.41 |
| 10 years | 14.2 | | 209.41 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xiao Chun Cao
CEO | Chief Executive Officer | 57 | - |
Hao Wu
PSD | President | 59 | 01/01/2020 |
Cheng Cheng Yang
DFI | Director of Finance/CFO | 52 | 21/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiao Chun Cao
BRD | Director/Board Member | 57 | 01/01/2005 |
Bing Hui Zhang
CHM | Chairman | 63 | 28/04/2020 |
Xiao Ping Ye
CHM | Chairman | 63 | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.06% | -3.81% | -1.17% | -49.09% | 678.46Cr | |
| -2.02% | -5.97% | -11.64% | -10.60% | 4.55TCr | |
| +2.79% | -5.01% | +17.18% | +26.18% | 3.34TCr | |
| +0.47% | -10.90% | +17.49% | +52.87% | 3.13TCr | |
| -2.25% | -2.42% | -5.92% | -20.53% | 2.93TCr | |
| -1.24% | -3.55% | +150.89% | +294.55% | 1.95TCr | |
| +1.39% | +3.06% | +58.83% | +111.91% | 1.48TCr | |
| -1.64% | -5.25% | +24.86% | +3.99% | 1.32TCr | |
| +0.26% | +4.17% | +44.47% | +134.63% | 1.34TCr | |
| -1.49% | -8.76% | +115.30% | +104.25% | 1.22TCr | |
| Average | -0.27% | -3.57% | +41.03% | +64.82% | 2.19TCr | |
| Weighted average by Cap. | -0.38% | -4.53% | +29.88% | +53.04% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 694.96Cr 100.77Cr 87Cr 78Cr 75Cr 137.23Cr 9.26TCr 143.62Cr 927.19Cr 371.45Cr 4.44TCr 378.2Cr 370.14Cr 16TCr | 787.59Cr 114.2Cr 98Cr 89Cr 85Cr 155.52Cr 10TCr 162.76Cr 1.05TCr 420.96Cr 5.03TCr 428.61Cr 419.47Cr 18TCr |
| Net income | 115.28Cr 17Cr 14Cr 13Cr 12Cr 23Cr 1.54TCr 24Cr 153.8Cr 62Cr 736.66Cr 63Cr 61Cr 2.63TCr | 140.99Cr 20Cr 18Cr 16Cr 15Cr 28Cr 1.88TCr 29Cr 188.1Cr 75Cr 900.97Cr 77Cr 75Cr 3.22TCr |
| Net Debt | -45Cr -6.57Cr -5.67Cr -5.12Cr -4.91Cr -8.95Cr -603.98Cr -9.37Cr -60Cr -24Cr -289.64Cr -25Cr -24Cr -1.04TCr | -56Cr -8.06Cr -6.95Cr -6.28Cr -6.02Cr -11Cr -740.96Cr -11Cr -74Cr -30Cr -355.33Cr -30Cr -30Cr -1.27TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | 57.37 ¥ | +1.06% | 68,58,261 |
| 05/26/05 | 56.77 ¥ | +1.27% | 67,87,222 |
| 04/26/04 | 56.06 ¥ | -1.44% | 66,94,681 |
| 03/26/03 | 56.88 ¥ | -3.33% | 96,01,432 |
| 02/26/02 | 58.84 ¥ | -1.34% | 82,63,968 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300347 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition